Astera Labs (NASDAQ:ALAB) Trading Up 9.7% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded up 9.7% on Monday . The company traded as high as $426.57 and last traded at $429.8260. Approximately 2,112,047 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 5,667,196 shares. The stock had previously closed at $391.74.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Roth Mkm reaffirmed a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Jefferies Financial Group reissued a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Stifel Nicolaus lifted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Finally, Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Stock Performance

The stock has a market capitalization of $82.79 billion, a price-to-earnings ratio of 326.36, a P/E/G ratio of 5.23 and a beta of 3.95. The company has a 50-day moving average of $301.08 and a 200-day moving average of $200.51.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Activity

In related news, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the transaction, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the completion of the transaction, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,968,942 shares of company stock worth $439,344,964 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the company. VectorGlobal IAG Inc. acquired a new stake in Astera Labs during the first quarter worth approximately $1,451,000. Empowered Funds LLC raised its holdings in Astera Labs by 5.1% in the 1st quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock valued at $1,053,000 after acquiring an additional 462 shares during the last quarter. Carmignac Gestion purchased a new position in shares of Astera Labs during the 1st quarter worth $6,576,000. Shariaportfolio Inc. purchased a new position in shares of Astera Labs during the 1st quarter worth $5,304,000. Finally, Glenmede Trust Co. NA boosted its holdings in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.